Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
Express Scripts
Moodys
Medtronic
Fuji
Boehringer Ingelheim
Farmers Insurance
Merck

Generated: November 14, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Linsitinib

« Back to Dashboard

US Patents for Linsitinib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Linsitinib ➤ Sign Up 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors OSI Pharmaceuticals, Inc. (Melville, NY) ➤ Sign Up
Linsitinib ➤ Sign Up 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors OSI Pharmaceuticals, Inc. (Ardsley, NY) ➤ Sign Up
Linsitinib ➤ Sign Up Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors OSI Pharmaceuticals, Inc. (Ardsley, NY) ➤ Sign Up
Linsitinib ➤ Sign Up Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors OSI Pharmaceuticals, LLC (Farmingdale, NY) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Linsitinib

Drugname Country Document Number Estimated Expiration Related US Patent
Linsitinib African Regional IP Organization (ARIPO) 2139 2024-04-02 ➤ Sign Up
Linsitinib Argentina 048518 2024-04-02 ➤ Sign Up
Linsitinib Austria 433979 2024-04-02 ➤ Sign Up
Linsitinib Australia 2005230818 2024-04-02 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Johnson and Johnson
Cantor Fitzgerald
Moodys
QuintilesIMS
Fuji
Boehringer Ingelheim
AstraZeneca
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.